Fertility and Sterility
Volume 95, Issue 1 , Pages 327-329 , January 2011

Hemorheologic profile in healthy women undergoing controlled ovarian stimulation

  • Cinzia Fatini, M.D, Ph.D.

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Center, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • Corresponding Author InformationReprint requests: Cinzia Fatini, M.D., Ph.D., Department of Medical and Surgical Critical Care, University of Florence, Viale Morgagni 85, 50134 Florence, Italy (FAX: 39-0557949929).
    • ,
  • Lucia Mannini, M.D.

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Center, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Elena Sticchi, B.S.

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Center, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Maria Novella Milanini, M.D.

      Affiliations

    • Department of Gynecology, Perinatology and Reproductive Medicine, University of Florence, Florence, Italy
    • ,
  • Gabriele Cioni, M.D.

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Center, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Agatina Alessandrello Liotta, B.S.

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Center, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Rosanna Abbate, M.D.

      Affiliations

    • Department of Medical and Surgical Critical Care, Thrombosis Center, University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
    • ,
  • Ivo Noci, M.D.

      Affiliations

    • Department of Gynecology, Perinatology and Reproductive Medicine, University of Florence, Florence, Italy

Received 4 February 2010 ,Revised 15 June 2010 ,Accepted 23 July 2010.

References 

  1. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study. Circulation. 2007;115:2119–2127
  2. Marossy A, Svorc P, Kron I, Gresová S. Hemorheology and circulation. Clin Hemorheol Microcirc. 2009;42:239–258
  3. Levin I, Gamzu R, Hasson Y, Lessing JB, Amit A, Shapira I, et al. Increased erythrocyte aggregation in ovarian hyperstimulation syndrome: a possible contributing factor in the pathophysiology of this disease. Hum Reprod. 2004;19:1076–1080
  4. Mannini L, Paniccia R, Cecchi E, Alessandrello Liotta A, Leprini E, Berloco P, et al. Reduced erythrocyte deformability and hypercoagulability in idiopathic sudden sensorineural hearing loss. Clin Hemorheol Microcirc. 2005;33:47–55
  5. Solá E, Vayá A, Corella D, Santaolaria ML, España F, Estellés A, et al. Erythrocyte hyperaggregation in obesity: determining factors and weight loss influence. Obesity (Silver Spring). 2007;15:2128–2134
  6. Pehlivanoglu B, Dikmenoglu N, Balkanci DZ. Effect of stress on erythrocyte deformability, influence of gender and menstrual cycle. Clin Hemorheol Microcirc. 2007;37:301–308
  7. Solerte SB, Fioravanti M, Spinillo A, Ferrari E, Guaschino S. Association between hormonal and haemorheological changes during the menstrual cycle in healthy women. Br J Obstet Gynaecol. 1988;95:1305–1308
  8. Ekerhovd E, Enskog A, Caidahl K, Klintland N, Nilsson L, Brännström M, et al. Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome. Hum Reprod. 2001;16:1334–1339
  9. Junge W, El-Samalouti V, Gerlinger C, Schaefers M. Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate. Eur J Obstet Gynecol Reprod Biol. 2009;147:195–200
  10. Klipping C, Marr J. Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism. Contraception. 2005;71:409–416
  11. Palomba S, Orio F, Russo T, Falbo A, Cascella T, Doldo P, et al. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas. Hum Reprod. 2004;19:1308–1314

 F.C. has nothing to disclose. L.M. has nothing to disclose. E.S. has nothing to disclose. M.N.M. has nothing to disclose. G.C. has nothing to disclose. A.A.L. has nothing to disclose. R.A. has nothing to disclose. I.N. has nothing to disclose.

PII: S0015-0282(10)02204-1

doi: 10.1016/j.fertnstert.2010.07.1078

Fertility and Sterility
Volume 95, Issue 1 , Pages 327-329 , January 2011

Article Tools